Ajinomoto logo

Ajinomoto

Last updated January 31, 2026
72
Innovation Areas
1,635
Inventors
14
Collaborations

Insufficient targeted payload delivery: AjinomotoRecent Research Landscape

Random conjugation leads to heterogeneous mixtures with unpredictable pharmacokinetics and reduced therapeutic efficacy. Achieving regioselectivity prevents inconsistent drug-to-antibody ratios and suboptimal binding affinity.